用于急性缺血性卒中水肿信号增强的非增强双能CT「X-Map 2.0」
本研究改进迭代束硬化校正(iBHC2)与X-map算法(X-map 2.0),对11例急性卒中患者行非增强双能CT回顾性分析。iBHC2较iBHC1降低颅骨附近CT值偏差,X-map 2.0较1.0降低患者间与患者内水肿信号变异,并与DWI信号呈强相关。
要点
- iBHC2降低颅骨附近CT值偏差,高kV与低kV图像均优于iBHC1。
- X-map 2.0较X-map 1.0降低患者间与患者内水肿信号变异。
- X-map 2.0联合ESE与DWI信号相关系数R=-0.733,为所比较方法中最高。
核心结论
- 通过改进iBHC与X-map算法,目标中列出的两个问题均得到解决。
- iBHC2改善了CT值偏差及全脑空间灰白质对比的可见性。
- iBHC2联合X-map 2.0与ESE显著降低水肿信号的患者内与患者间变异,并与DWI信号强度呈强相关。
研究设计与样本
- 回顾性研究,纳入11例因急性卒中症状就诊于急诊科的患者(3男8女,平均年龄76.3岁,范围68-90岁)。
- 图像分别用旧iBHC(iBHC1)与新iBHC(iBHC2)重建,并测量颅骨附近CT值偏差。
- X-map 2.0与X-map 1.0均由iBHC2图像计算,分别在有、无基于物质分解的水肿信号增强(ESE)处理下比较。
- 在5例于NE-DE-CT后2小时内行DWI的患者中,于缺血病灶及附近测量X-map、低kV与高kV CT及DWI图像信号。
关键影像表现/征象
- iBHC2高kV图像CT值偏差为2.5±2.0 HU(95%CI 1.3-3.8 HU),低于iBHC1的6.9±2.3 HU(95%CI 5.4-8.3 HU),P<0.01。
- iBHC2低kV图像CT值偏差为1.5±3.6 HU(95%CI -0.8至3.7 HU),低于iBHC1的12.8±3.3 HU(95%CI 10.7-14.8 HU),P<0.01。
诊断标准与关键数值
- iBHC1高kV图像CT值偏差6.9±2.3 HU(95%CI 5.4-8.3 HU)vs iBHC2 2.5±2.0 HU(95%CI 1.3-3.8 HU),iBHC2较低,P<0.01。
- iBHC1低kV图像CT值偏差12.8±3.3 HU(95%CI 10.7-14.8 HU)vs iBHC2 1.5±3.6 HU(95%CI -0.8至3.7 HU),iBHC2较低,P<0.01。
- 有ESE时患者间变异X-map 1.0为19.0(95%CI 13.3-22.4)vs X-map 2.0为4.3(95%CI 3.0-7.6),X-map 2.0较低,P<0.01。
- 无ESE时患者间变异X-map 1.0为12.0(95%CI 8.4-21.0)vs X-map 2.0为3.0(95%CI 2.1-5.3),X-map 2.0较低,P<0.01。
- 有ESE时患者内变异X-map 1.0为8.5(95%CI 7.3-10.1)vs X-map 2.0为6.2(95%CI 5.3-7.3),X-map 2.0较低,P=0.0122;无ESE时X-map 1.0为6.3(95%CI 5.5-7.6)vs X-map 2.0为4.1(95%CI 3.6-4.9),X-map 2.0较低,P<0.01。
临床应用与阅片要点
- 与DWI信号相关性最好的3个相关系数:X-map 2.0联合ESE的R=-0.733(95%CI -0.845至-0.560,P<0.001),高kV CT的R=-0.642(95%CI -0.787至-0.429,P<0.001),X-map 1.0联合ESE的R=-0.609(95%CI -0.766至-0.384,P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: A novel imaging technique ("X-map") has been developed to identify acute ischemic lesions for stroke patients using non-contrast-enhanced dual-energy computed tomography (NE-DE-CT). Using the 3-material decomposition technique, the original X-map ("X-map 1.0") eliminates fat and bone from the images, suppresses the gray matter (GM)-white matter (WM) tissue contrast, and makes signals of edema induced by severe ischemia easier to detect. The aim of this study was to address the following 2 problems with the X-map 1.0: (1) biases in CT numbers (or artifacts) near the skull of NE-DE-CT images and (2) large intrapatient and interpatient variations in X-map 1.0 values.
MATERIALS AND METHODS: We improved both an iterative beam-hardening correction (iBHC) method and the X-map algorithm. The new iBHC (iBHC2) modeled x-ray physics more accurately. The new X-map ("X-map 2.0") estimated regional GM values-thus, maximizing the ability to suppress the GM-WM contrast, make edema signals quantitative, and enhance the edema signals that denote an increased water density for each pixel. We performed a retrospective study of 11 patients (3 men, 8 women; mean age, 76.3 years; range, 68-90 years) who presented to the emergency department with symptoms of acute stroke. Images were reconstructed with the old iBHC (iBHC1) and the iBHC2, and biases in CT numbers near the skull were measured. Both X-map 2.0 maps and X-map 1.0 maps were computed from iBHC2 images, both with and without a material decomposition-based edema signal enhancement (ESE) process. X-map values were measured at 5 to 9 locations on GM without infarct per patient; the mean value was calculated for each patient (we call it the patient-mean X-map value) and subtracted from the measured X-map values to generate zero-mean X-map values. The standard deviation of the patient-mean X-map values over multiple patients denotes the interpatient variation; the standard deviation over multiple zero-mean X-map values denotes the intrapatient variation. The Levene F test was performed to assess the difference in the standard deviations with different algorithms. Using 5 patient data who had diffusion weighted imaging (DWI) within 2 hours of NE-DE-CT, mean values at and near ischemic lesions were measured at 7 to 14 locations per patient with X-map images, CT images (low kV and high kV), and DWI images. The Pearson correlation coefficient was calculated between a normalized increase in DWI signals and either X-map or CT.
RESULTS: The bias in CT numbers was lower with iBHC2 than with iBHC1 in both high- and low-kV images (2.5 ± 2.0 HU [95% confidence interval (CI), 1.3-3.8 HU] for iBHC2 vs 6.9 ± 2.3 HU [95% CI, 5.4-8.3 HU] for iBHC1 with high-kV images, P < 0.01; 1.5 ± 3.6 HU [95% CI, -0.8 to 3.7 HU] vs 12.8 ± 3.3 HU [95% CI, 10.7-14.8 HU] with low-kV images, P < 0.01). The interpatient variation was smaller with X-map 2.0 than with X-map 1.0, both with and without ESE (4.3 [95% CI, 3.0-7.6] for X-map 2.0 vs 19.0 [95% CI, 13.3-22.4] for X-map 1.0, both with ESE, P < 0.01; 3.0 [95% CI, 2.1-5.3] vs 12.0 [95% CI, 8.4-21.0] without ESE, P < 0.01). The intrapatient variation was also smaller with X-map 2.0 than with X-map 1.0 (6.2 [95% CI, 5.3-7.3] vs 8.5 [95% CI, 7.3-10.1] with ESE, P = 0.0122; 4.1 [95% CI, 3.6-4.9] vs 6.3 [95% CI, 5.5-7.6] without ESE, P < 0.01). The best 3 correlation coefficients (R) with DWI signals were -0.733 (95% CI, -0.845 to -0.560, P < 0.001) for X-map 2.0 with ESE, -0.642 (95% CI, -0.787 to -0.429, P < 0.001) for high-kV CT, and -0.609 (95% CI, -0.766 to -0.384, P < 0.001) for X-map 1.0 with ESE.
CONCLUSION: Both of the 2 problems outlined in the objectives have been addressed by improving both iBHC and X-map algorithm. The iBHC2 improved the bias in CT numbers and the visibility of GM-WM contrast throughout the brain space. The combination of iBHC2 and X-map 2.0 with ESE decreased both intrapatient and interpatient variations of edema signals significantly and had a strong correlation with DWI signals in terms of the strength of edema signals.
引用
- Taguchi K, Itoh T, Fuld MK, et al. "X-Map 2.0" for Edema Signal Enhancement for Acute Ischemic Stroke Using Non-Contrast-Enhanced Dual-Energy Computed Tomography. Invest Radiol. 2018. PMID: 29543692. doi:10.1097/RLI.0000000000000461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。